Novel effects of CCN3 that may direct the differentiation of chondrocytes
Authors:
- Satoshi KubotaSKSatoshi Kubota
- Takashi NishidaTNTakashi Nishida
- Harumi KawakiHKHarumi Kawaki
- Bernard PerbalBPBernard Perbal
- Seiji IidaSISeiji Iida
- Masaharu TakigawaMTMasaharu Takigawa
- 23 August 2011
- journal article
- research article
- Published by Wiley in FEBS Letters
- Vol. 585 (19) , 3033-3040
Abstract
Identification and characterization of local molecules directing the differentiation of chondrocytes to either transient or permanent cartilage are major issues in cartilage biology. Here, we found CCN family protein 3 (CCN3) was abundantly produced in rat developing epiphyseal cartilage. Evaluations in vitro showed that CCN3 repressed epiphyseal chondrocyte proliferation, while promoting matrix production in multiple assays performed. Furthermore, CCN3 enhanced the articular chondrocytic phenotype; whereas it repressed the one representing endochondral ossification. Additionally, the phenotype of growth plate chondrocytes and chondrogenic progenitors also appeared to be affected by CCN3 in a similar manner. These findings suggest a significant role of CCN3 in inducing chondrocytes to articular ones during joint formation.Keywords
Funding Information
- Japan Society for the Promotion of Science
- Terumo Life Science Foundation
- Japanese Ministry of Education, Culture, Sports, Science, and Technology
- French Ministry of education (EA1556)
- European PROTHETS (503036)
This publication has 23 references indexed in Scilit:
- Functions and mechanisms of action of CCN matricellular proteinsThe International Journal of Biochemistry & Cell Biology, 2009
- Inhibitory effect of CT domain of CCN3/NOV on proliferation and differentiation of osteogenic mesenchymal stem cells, Kusa-A1Biochemical and Biophysical Research Communications, 2008
- A distinct cohort of progenitor cells participates in synovial joint and articular cartilage formation during mouse limb skeletogenesisDevelopmental Biology, 2008
- Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) geneBMC Developmental Biology, 2008
- CCN3 is a novel endogenous PDGF-regulated inhibitor of glomerular cell proliferationKidney International, 2008
- Antiproliferative activity of CCN3: Involvement of the C‐terminal module and post‐translational regulationJournal of Cellular Biochemistry, 2007
- New Target Genes for NOV/CCN3 in Chondrocytes: TGF-β2 and Type X CollagenJournal of Bone and Mineral Research, 2005
- In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell typeOncogene, 2005
- Role of CTGF/HCS24/ecogenin in skeletal growth controlJournal of Cellular Physiology, 2003
- Improved method for obtaining 3-microns cryosections for immunocytochemistry.Journal of Histochemistry & Cytochemistry, 1990